Insulet (PODD) Tops Q2 EPS by 21c
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $166.82 --0%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
GLXY, CRVL, SGHC, More
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
GLXY, CRVL, SGHC, More
Join SI Premium – FREE
(Updated - August 5, 2026 7:19 AM EDT)
Insulet (NASDAQ: PODD) reported Q2 EPS of $1.66, $0.21 better than the analyst estimate of $1.45. Revenue for the quarter came in at $801.7 million versus the consensus estimate of $787.82 million.
Raises adjusted EPS growth guidance from >25% to >30%. Cuts FY revenue outlook growth from 21-23% to 20-22%.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- Griffon Corp (GFF) Tops Q3 EPS by 18c
- Advantage Solutions Inc. (ADV) Misses Q2 EPS by 458c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
